BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

608 related articles for article (PubMed ID: 26404765)

  • 1. Eliciting the mitochondrial unfolded protein response by nicotinamide adenine dinucleotide repletion reverses fatty liver disease in mice.
    Gariani K; Menzies KJ; Ryu D; Wegner CJ; Wang X; Ropelle ER; Moullan N; Zhang H; Perino A; Lemos V; Kim B; Park YK; Piersigilli A; Pham TX; Yang Y; Ku CS; Koo SI; Fomitchova A; Cantó C; Schoonjans K; Sauve AA; Lee JY; Auwerx J
    Hepatology; 2016 Apr; 63(4):1190-204. PubMed ID: 26404765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nicotinamide riboside, an NAD+ precursor, attenuates the development of liver fibrosis in a diet-induced mouse model of liver fibrosis.
    Pham TX; Bae M; Kim MB; Lee Y; Hu S; Kang H; Park YK; Lee JY
    Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2451-2463. PubMed ID: 31195117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NAD
    Li DJ; Sun SJ; Fu JT; Ouyang SX; Zhao QJ; Su L; Ji QX; Sun DY; Zhu JH; Zhang GY; Ma JW; Lan XT; Zhao Y; Tong J; Li GQ; Shen FM; Wang P
    Theranostics; 2021; 11(9):4381-4402. PubMed ID: 33754067
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibiting poly ADP-ribosylation increases fatty acid oxidation and protects against fatty liver disease.
    Gariani K; Ryu D; Menzies KJ; Yi HS; Stein S; Zhang H; Perino A; Lemos V; Katsyuba E; Jha P; Vijgen S; Rubbia-Brandt L; Kim YK; Kim JT; Kim KS; Shong M; Schoonjans K; Auwerx J
    J Hepatol; 2017 Jan; 66(1):132-141. PubMed ID: 27663419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined Treatment with L-Carnitine and Nicotinamide Riboside Improves Hepatic Metabolism and Attenuates Obesity and Liver Steatosis.
    Salic K; Gart E; Seidel F; Verschuren L; Caspers M; van Duyvenvoorde W; Wong KE; Keijer J; Bobeldijk-Pastorova I; Wielinga PY; Kleemann R
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31491949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotinamide riboside attenuates alcohol induced liver injuries via activation of SirT1/PGC-1α/mitochondrial biosynthesis pathway.
    Wang S; Wan T; Ye M; Qiu Y; Pei L; Jiang R; Pang N; Huang Y; Liang B; Ling W; Lin X; Zhang Z; Yang L
    Redox Biol; 2018 Jul; 17():89-98. PubMed ID: 29679894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic steatosis induced by nicotine plus Coca-Cola™ is prevented by nicotinamide riboside (NR).
    Rivera JC; Espinoza-Derout J; Hasan KM; Molina-Mancio J; Martínez J; Lao CJ; Lee ML; Lee DL; Wilson J; Sinha-Hikim AP; Friedman TC
    Front Endocrinol (Lausanne); 2024; 15():1282231. PubMed ID: 38756999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic potential of nicotinamide adenine dinucleotide for nonalcoholic fatty liver disease.
    Gual P; Postic C
    Hepatology; 2016 Apr; 63(4):1074-7. PubMed ID: 26661503
    [No Abstract]   [Full Text] [Related]  

  • 9. Effective treatment of mitochondrial myopathy by nicotinamide riboside, a vitamin B3.
    Khan NA; Auranen M; Paetau I; Pirinen E; Euro L; Forsström S; Pasila L; Velagapudi V; Carroll CJ; Auwerx J; Suomalainen A
    EMBO Mol Med; 2014 Jun; 6(6):721-31. PubMed ID: 24711540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sleeve gastrectomy ameliorated high-fat diet (HFD)-induced non-alcoholic fatty liver disease and upregulated the nicotinamide adenine dinucleotide +/ Sirtuin-1 pathway in mice.
    Hua R; Wang GZ; Shen QW; Yang YP; Wang M; Wu M; Shao YK; He M; Zang Y; Yao QY; Zhang ZY
    Asian J Surg; 2021 Jan; 44(1):213-220. PubMed ID: 32712045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting sirtuin activity with nicotinamide riboside reduces neuroinflammation in a GWI mouse model.
    Joshi U; Evans JE; Pearson A; Saltiel N; Cseresznye A; Darcey T; Ojo J; Keegan AP; Oberlin S; Mouzon B; Paris D; Klimas N; Sullivan K; Mullan M; Crawford F; Abdullah L
    Neurotoxicology; 2020 Jul; 79():84-94. PubMed ID: 32343995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The NAD(+) precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity.
    Cantó C; Houtkooper RH; Pirinen E; Youn DY; Oosterveer MH; Cen Y; Fernandez-Marcos PJ; Yamamoto H; Andreux PA; Cettour-Rose P; Gademann K; Rinsch C; Schoonjans K; Sauve AA; Auwerx J
    Cell Metab; 2012 Jun; 15(6):838-47. PubMed ID: 22682224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nicotinamide adenine dinucleotide biosynthesis promotes liver regeneration.
    Mukherjee S; Chellappa K; Moffitt A; Ndungu J; Dellinger RW; Davis JG; Agarwal B; Baur JA
    Hepatology; 2017 Feb; 65(2):616-630. PubMed ID: 27809334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Troxerutin improves hepatic lipid homeostasis by restoring NAD(+)-depletion-mediated dysfunction of lipin 1 signaling in high-fat diet-treated mice.
    Zhang ZF; Fan SH; Zheng YL; Lu J; Wu DM; Shan Q; Hu B
    Biochem Pharmacol; 2014 Sep; 91(1):74-86. PubMed ID: 25026599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nicotinamide riboside supplementation exerts an anti-obesity effect and prevents inflammation and fibrosis in white adipose tissue of female diet-induced obesity mice.
    Kim MB; Pham TX; vanLuling M; Kostour V; Kang H; Corvino O; Jang H; Odell W; Bae M; Park YK; Lee JY
    J Nutr Biochem; 2022 Sep; 107():109058. PubMed ID: 35643283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of NRK1 ameliorates diet- and age-induced hepatic steatosis and insulin resistance.
    Fan R; Cui J; Ren F; Wang Q; Huang Y; Zhao B; Wei L; Qian X; Xiong X
    Biochem Biophys Res Commun; 2018 Jun; 500(2):476-483. PubMed ID: 29678570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous nicotinamide riboside metabolism protects against diet-induced liver damage.
    Sambeat A; Ratajczak J; Joffraud M; Sanchez-Garcia JL; Giner MP; Valsesia A; Giroud-Gerbetant J; Valera-Alberni M; Cercillieux A; Boutant M; Kulkarni SS; Moco S; Canto C
    Nat Commun; 2019 Sep; 10(1):4291. PubMed ID: 31541116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NAD
    Dall M; Hassing AS; Treebak JT
    J Physiol; 2022 Mar; 600(5):1135-1154. PubMed ID: 33932956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nicotinamide improves glucose metabolism and affects the hepatic NAD-sirtuin pathway in a rodent model of obesity and type 2 diabetes.
    Yang SJ; Choi JM; Kim L; Park SE; Rhee EJ; Lee WY; Oh KW; Park SW; Park CY
    J Nutr Biochem; 2014 Jan; 25(1):66-72. PubMed ID: 24314867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicotinamide riboside exerts protective effect against aging-induced NAFLD-like hepatic dysfunction in mice.
    Han X; Bao X; Lou Q; Xie X; Zhang M; Zhou S; Guo H; Jiang G; Shi Q
    PeerJ; 2019; 7():e7568. PubMed ID: 31523515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.